Investors : Overview

Corporate Profile

Verenium Corporation (Nasdaq: VRNM) is a leading developer of cellulosic ethanol technology and a pioneer in the development of high-performance specialty enzymes for applications within the biofuels, industrial, and health and nutrition markets. The Company possesses the full set of capabilities needed to make cellulosic ethanol a commercial reality.

Verenium currently operates one of the nation’s first cellulosic ethanol pilot plants, an R&D facility, in Jennings, Louisiana and recently completed mechanical construction and began start-up and the commissioning of a 1.4 million gallon-per-year demonstration-scale facility to produce cellulosic ethanol.

Recent News
DateTitle 
11/18/08Verenium Announces Organizational Changes
CAMBRIDGE, Mass., Nov. 18 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes today announced the departure of John A. McCarthy, Jr. from the position of Chief Financial Officer effective immediately. Jeffrey G. Black, Vice President and Chief Accounting Officer of Verenium since April of 2005, will serve as interim Chief Financial Officer while Verenium undertakes a se... 
Printer Friendly Version
11/10/08Verenium Reports Financial Results for the Third Quarter 2008
- Continues execution against corporate objectives - CAMBRIDGE, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today reported financial results for the third quarter of 2008 and provided recent Company highlights and accomplishments. "I am very pleased with our performance against key 2008 business objectives, despite an ever challe... 
Printer Friendly Version
11/05/08Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
CAMBRIDGE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that Carlos A. Riva, President and Chief Executive Officer, will speak at the upcoming Credit Suisse Alternative Energy Conference as part of a panel discussion on biofuels and the future of transportation. The panel is scheduled from 11:00 - 12:00 p.m. ET on Wednesday, Novembe... 
Printer Friendly Version
11/03/08Verenium Corporation to Announce Third Quarter 2008 Financial Results
CAMBRIDGE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that it will release third quarter 2008 financial results on Monday, November 10, 2008 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Monday, November 10 at 5:00 p.m. ET. The call may be accessed by dialing 8... 
Printer Friendly Version

>> More

Upcoming Events
There are currently no events scheduled.

>> More


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

VRNM (Common Stock)

ExchangeNASDAQ (US Dollar)
Price$0.69
Change (%) 0.19 (21.59%)
Volume362,441
Data as of 11/20/08 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote